Chenxin Chen

发表

Cardiotoxicity Induced by Immune Checkpoint Inhibitors: A Pharmacovigilance Study From 2014 to 2019 Based on FAERS

Lianhu Wei, Jin-fang Xu, X. Ye, 2021, Frontiers in Pharmacology.

Temporal trends, predictors of blood transfusion and in‐hospital outcomes among patients with severe burn injury in the United States—A national database‐based analysis

Chi Peng, Fan Yang, Jia He, 2022, Transfusion.

Incidence and outcomes of acute high-risk chest pain diseases during pregnancy and puerperium

Yingyi Qin, Suxuan Liu, Qian He, 2022, Frontiers in Cardiovascular Medicine.

Toxicity signals associated with secukinumab: A pharmacovigilance study based on the United States Food and Drug Administration Adverse Event Reporting System database

X. Ye, Xiao-jing Guo, Jia He, 2022, British journal of clinical pharmacology.

Safety of sugammadex for reversal of neuromuscular block: A postmarketing study based on the World Health Organization pharmacovigilance database

Jin-fang Xu, X. Ye, Xiao-jing Guo, 2022, British journal of clinical pharmacology.

Cardiovascular Toxicities of Ibrutinib: A Pharmacovigilance Study Based on the United States Food and Drug Administration Adverse Event Reporting System Database

X. Ye, Xiao-jing Guo, Jia He, 2023, Pharmaceuticals.

Drug-induced Stevens-Johnson syndrome: a disproportionality analysis from the pharmacovigilance database of the World Health Organization

X. Ye, Xiao-jing Guo, Jia He, 2022, Expert opinion on drug safety.

Adverse events of alpelisib: A postmarketing study of the World Health Organization pharmacovigilance database

X. Ye, Xiao-jing Guo, Jia He, 2021, British journal of clinical pharmacology.

Temporal trend and factors associated with post-endoscopic retrograde cholangiopancreatography pancreatitis in children in the USA: a nationwide, retrospective cohort study

Jin-fang Xu, Yi Cheng, Ronghui Zhu, 2023, European Journal of Pediatrics.

Temporal trends and outcomes in acute ischaemic stroke patients with a current or historical diagnosis of cancer

Chi Peng, Zhichao Jin, Fan Yang, 2023, European journal of neurology.

Thromboembolic events in Janus kinase inhibitors: A pharmacovigilance study from 2012 to 2021 based on the Food and Drug Administration's Adverse Event Reporting System

X. Ye, Rui Wang, Jia He, 2022 .

Safety of selinexor as the only exportin 1 (XPO1) inhibitor so far: a post-marketing study based on the world Health Organization pharmacovigilance database (Vigibase)

Jin-fang Xu, X. Ye, Xiao-jing Guo, 2023, Expert opinion on drug safety.

Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database

Jin-fang Xu, X. Ye, Xiao-jing Guo, 2023, International Journal of Clinical Pharmacy.

In-hospital mortality and length of hospital stay in infants requiring tracheostomy with bronchopulmonary dysplasia.

Jin-fang Xu, Ronghui Zhu, Chenxin Chen, 2023, Journal of Perinatology.

Temporal trends, in-hospital outcomes, and risk factors of acute myocardial infarction among patients with epilepsy in the United States: a retrospective national database analysis from 2008 to 2017

Chenxin Chen, Zhemin Pan, Xi Xu, 2024, Frontiers in Neurology.